Scientific Concept of the National Cohort (status ... - Nationale Kohorte
Scientific Concept of the National Cohort (status ... - Nationale Kohorte
Scientific Concept of the National Cohort (status ... - Nationale Kohorte
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
89<br />
A.3 Study design<br />
The device will also be equipped with an ultrasound probe suitable for performing <strong>the</strong> measurement<br />
<strong>of</strong> intima–media thickness <strong>of</strong> <strong>the</strong> carotid artery.<br />
measurement <strong>of</strong> arterial stiffness and ankle–brachial index<br />
Arterial stiffness is defined as a reduction in arterial distensibility. The physiological mechanisms<br />
underlying arterial stiffening occurring with age and <strong>the</strong> accumulation <strong>of</strong> cardiovascular<br />
risk factors include breaks in elastin fibers, accumulation <strong>of</strong> collagen, fibrosis, inflammation,<br />
medial smooth muscle necrosis, calcifications, and diffusion <strong>of</strong> macromolecules<br />
within <strong>the</strong> arterial wall 567 . These phenomena have been shown to develop simultaneously in<br />
coronary arteries and <strong>the</strong> aorta 568 . The association <strong>of</strong> specific measures <strong>of</strong> arterial stiffness<br />
(such as <strong>the</strong> augmentation index and central blood pressure) with target-organ damage and<br />
cardiovascular outcome is greater than that <strong>of</strong> brachial blood pressure 569 , i.e., <strong>the</strong> increase<br />
in cardiovascular risk can be estimated better from central than from brachial blood pressure<br />
measurements 570 . Recent guidelines for <strong>the</strong> management <strong>of</strong> hypertension call for assessment<br />
<strong>of</strong> arterial stiffness to guide <strong>the</strong>rapeutic decisions 571 .<br />
Moreover, alterations in vascular stiffness may cause diastolic and systolic heart failure, for<br />
example, as a result <strong>of</strong> left ventricular hypertrophy, and subendocardial ischemia or coronary<br />
artery disease. However, <strong>the</strong> potential link between measures <strong>of</strong> vascular stiffness<br />
and ventricular dysfunction (“arterioventriculo coupling”) has not been addressed in large<br />
population-based cohort studies. Fur<strong>the</strong>rmore, <strong>the</strong>re is insufficient knowledge on determinants<br />
<strong>of</strong> arterial stiffness.<br />
The gold standard for measuring arterial stiffness is pulse wave velocity 572 , as measured by<br />
<strong>the</strong> Sphygmocor device 573 , which has also been used most frequently. However, newer devices<br />
which are easier to use and less observer-dependent have recently become available<br />
(Vascular Explorer, Vicorder) 574 . In practice, pulse wave velocity is calculated as <strong>the</strong> traveling<br />
time or distance <strong>of</strong> <strong>the</strong> pulse wave between two measuring sites 575 . The assessment<br />
<strong>of</strong> <strong>the</strong> wave reflection in <strong>the</strong> arterial system, <strong>the</strong> pulse wave analysis, gives information on<br />
arterial stiffness, central blood pressure, and subendocardial flow reserve.<br />
The ankle–brachial index is a noninvasive, rapid, and quantitative measure <strong>of</strong> PAD, derived<br />
from brachial and ankle systolic blood pressure values. The ankle–brachial index is inversely<br />
associated with CVD events, mortality, and <strong>the</strong> progression to critical leg ischemia,<br />
rest pain, and ulceration 576-579 . It is one <strong>of</strong> <strong>the</strong> standard tools for diagnosing lower extremity<br />
PAD and is used for PAD screening and <strong>the</strong>rapeutic efficacy monitoring. Lower extremity<br />
PAD can be symptomatic (intermittent claudication) but is <strong>of</strong>ten asymptomatic. The use<br />
<strong>of</strong> an ankle–brachial index < 0.9 to diagnose PAD has a sensitivity <strong>of</strong> 0.95 and specificity<br />
<strong>of</strong> 0.99 and is highly reproducible 580 . However, fur<strong>the</strong>r information is needed to improve<br />
our understanding <strong>of</strong> early developments and determinants <strong>of</strong> progressive reduction in <strong>the</strong><br />
ankle–brachial index, and to better assess <strong>the</strong> predictive ability <strong>of</strong> reduced ankle–brachial<br />
index for future cardiovascular events.<br />
Procedure <strong>of</strong> measurement:<br />
Ankle–brachial index, pulse wave analysis, and velocity will be measured at a controlled room<br />
temperature (22°C) after <strong>the</strong> subject has rested for at least 5–10 min in a supine position.<br />
For <strong>the</strong>se measurements, several devices are available, among <strong>the</strong>m <strong>the</strong> SpyhgmoCor<br />
device (<strong>the</strong> current gold standard for measuring pulse wave analysis and velocity) 572 , <strong>the</strong><br />
Vascular Explorer, and <strong>the</strong> Vicorder (<strong>the</strong> latter two being new multifunctional devices for<br />
measuring ankle–brachial index and pulse wave velocity). To determine <strong>the</strong> ankle–brachial<br />
A.3